Role of a Novel THAP-Family Protein in Transcription and Cancer Cell Function
新型 THAP 家族蛋白在转录和癌细胞功能中的作用
基本信息
- 批准号:7741168
- 负责人:
- 金额:$ 31.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsApoptosisArtsBiochemicalBiologicalBiological AssayBiological ModelsBreast Cancer CellCDH1 geneCarcinomaCell AdhesionCell modelCell physiologyCellsCessation of lifeColonColon CarcinomaComplexDevelopmentDisseminated Malignant NeoplasmDown-RegulationE-CadherinEpithelialEventExtracellular MatrixGenesGeneticGenetic TranscriptionHistonesHumanInvestigationKnowledgeLinkMalignant - descriptorMalignant NeoplasmsMediatingMessenger RNAMicroarray AnalysisMolecularMolecular TargetMusNeoplasm MetastasisNormal CellOrganPhysiologicalPhysiologyPlayProcessProtein FamilyProteinsRepressionRoleSignal TransductionStagingTestingTherapeutic InterventionTight JunctionsTissue MicroarrayTissuesTranscription Repressor/CorepressorTranscriptional RegulationTransferaseTumor Suppressor GenesUp-RegulationWorkXenograft ModelXenograft procedurebasecancer cellcell motilitychromatin immunoprecipitationgene repressiongenome-widemalignant breast neoplasmmaspinmembermigrationneoplastic cellnoveloverexpressionpreventpublic health relevanceresearch studytranscription factortumortumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Transcriptional regulation plays a critical role in normal cell and organ differentiation, development and physiology in humans. Not surprisingly, up or downregulation of transcription factors and their coregulators has been tightly linked to tumor development and the progression to malignant and metastatic stages. Cancer cells originate primarily from epithelial tissues. Accumulating evidence suggests that during cancer progression, cells begin to redistribute or downregulate proteins involved in maintaining cell adherens and tight junctions. These changes and others promote a loss of cell-cell and cell-matrix interactions and permit cell motility and invasion of neighboring tissues. While approximately 90% of all cancer deaths occur because of tumor metastasis, very few therapies are available that are effective in preventing metastasis. One way to overcome this limitation is to gain a complete understanding of the genetic and signaling networks that promote and modulate tumor cell motility and metastasis. The Thanatos associated protein (THAP) family is comprised of 12 members in the human, and only 3 members have been partially characterized. Recently we observed that THAP11, a member of the THAP family is differentially expressed in cancer cells. How THAP11 overexpression contributes to cancer cell function is completely unknown and thus represents an exciting and novel field of investigation. Based on our preliminary results, we hypothesize that THAP11 is a transcriptional repressor that plays a critical role in cancer cell function by directly regulating expression of key genes involved in intercellular and cell-matrix interactions. Since alteration of these interactions is a key initial event in metastasis, we propose that THAP11 represents a novel and critical transcriptional regulator of cancer cell function. We will undertake state-of-the-art molecular, cellular, physiologic and genome-wide analyses to define the impact of THAP11 overexpression and its mechanism of action in cancer cell function in three integrated specific aims. The proposed studies will greatly advance our knowledge of cancer progression and metastasis, and may provide a molecular target for therapeutic intervention. PUBLIC HEALTH RELEVANCE: While approximately 90% of all cancer deaths occur because of tumor metastasis, very few therapies are available that are effective in preventing metastasis. One way to overcome this limitation is to gain a complete understanding of the genetic and signaling networks that promote and modulate tumor cell motility and metastasis. In this work, we will determine the role of a novel human protein termed THAP11 in cancer cell function. The proposed studies will greatly advance our knowledge of cancer progression and metastasis, and may provide a molecular target for therapeutic intervention.
描述(由申请人提供):转录调控在人类正常的细胞和器官分化、发育和生理学中起着关键作用。不足为奇的是,转录因子及其辅助调节因子的上调或下调与肿瘤的发展以及向恶性和转移阶段的进展密切相关。癌细胞主要来源于上皮组织。越来越多的证据表明,在癌症进展过程中,细胞开始重新分配或下调与维持细胞黏附和紧密连接有关的蛋白质。这些变化和其他变化促进了细胞-细胞和细胞-基质相互作用的丧失,并允许细胞移动和侵袭邻近组织。虽然所有癌症死亡中约90%是由于肿瘤转移而发生的,但有效防止转移的治疗方法很少。克服这一局限的一种方法是完全了解促进和调节肿瘤细胞运动和转移的遗传和信号网络。人类Thanatos相关蛋白(Thanatos Association Protein,TAP)家族由12个成员组成,只有3个成员具有部分特征。最近,我们观察到THAP11是TAPP家族的成员之一,在癌细胞中差异表达。THAP11过表达对癌细胞功能的影响是完全未知的,因此代表着一个令人兴奋和新颖的研究领域。根据我们的初步结果,我们假设THAP11是一个转录抑制因子,通过直接调节参与细胞间和细胞-基质相互作用的关键基因的表达,在癌细胞功能中发挥关键作用。由于这些相互作用的改变是转移过程中的一个关键初始事件,我们认为THAP11是癌细胞功能的一个新的和关键的转录调节因子。我们将进行最先进的分子、细胞、生理和基因组分析,以确定THAP11过表达的影响及其在三个整合的特定目标中的作用机制。所提出的研究将极大地提高我们对癌症进展和转移的认识,并可能为治疗干预提供分子靶点。公共卫生相关性:虽然所有癌症死亡中约90%是由于肿瘤转移而发生的,但有效防止转移的治疗方法很少。克服这一局限的一种方法是完全了解促进和调节肿瘤细胞运动和转移的遗传和信号网络。在这项工作中,我们将确定一种名为THAP11的新型人类蛋白在癌细胞功能中的作用。所提出的研究将极大地提高我们对癌症进展和转移的认识,并可能为治疗干预提供分子靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBABRATA CHAKRAVARTI其他文献
DEBABRATA CHAKRAVARTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBABRATA CHAKRAVARTI', 18)}}的其他基金
Integrative Genomewide Analyses of HMGA2 Impact on Uterine Leiomyomas
HMGA2 对子宫平滑肌瘤影响的综合全基因组分析
- 批准号:
10153844 - 财政年份:2019
- 资助金额:
$ 31.64万 - 项目类别:
Integrative Genomewide Analyses of HMGA2 Impact on Uterine Leiomyomas
HMGA2 对子宫平滑肌瘤影响的综合全基因组分析
- 批准号:
10396488 - 财政年份:2019
- 资助金额:
$ 31.64万 - 项目类别:
Integrative Genomewide Analyses of HMGA2 Impact on Uterine Leiomyomas
HMGA2 对子宫平滑肌瘤影响的综合全基因组分析
- 批准号:
10613378 - 财政年份:2019
- 资助金额:
$ 31.64万 - 项目类别:
Probing Mediator 12 function in uterine fibroids
探索Mediator 12在子宫肌瘤中的功能
- 批准号:
9130607 - 财政年份:2015
- 资助金额:
$ 31.64万 - 项目类别:
Regulatory Mechanisms in Hormonal and Transcriptional Signaling
激素和转录信号传导的调节机制
- 批准号:
8074146 - 财政年份:2010
- 资助金额:
$ 31.64万 - 项目类别:
Role of a Novel THAP-Family Protein in Transcription and Cancer Cell Function
新型 THAP 家族蛋白在转录和癌细胞功能中的作用
- 批准号:
8305762 - 财政年份:2009
- 资助金额:
$ 31.64万 - 项目类别:
Role of a Novel THAP-Family Protein in Transcription and Cancer Cell Function
新型 THAP 家族蛋白在转录和癌细胞功能中的作用
- 批准号:
8107675 - 财政年份:2009
- 资助金额:
$ 31.64万 - 项目类别:
Roles of Nuclear Receptors in Uterine Leiomyoma Proliferation and Fibrosis
核受体在子宫平滑肌瘤增殖和纤维化中的作用
- 批准号:
9162083 - 财政年份:2009
- 资助金额:
$ 31.64万 - 项目类别:
Roles of Nuclear Receptors in Uterine Leiomyoma Proliferation and Fibrosis
核受体在子宫平滑肌瘤增殖和纤维化中的作用
- 批准号:
8934760 - 财政年份:2009
- 资助金额:
$ 31.64万 - 项目类别:
Role of a Novel THAP-Family Protein in Transcription and Cancer Cell Function
新型 THAP 家族蛋白在转录和癌细胞功能中的作用
- 批准号:
8546985 - 财政年份:2009
- 资助金额:
$ 31.64万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 31.64万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 31.64万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 31.64万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 31.64万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 31.64万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 31.64万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 31.64万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 31.64万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 31.64万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 31.64万 - 项目类别: